drugset / Trial / NCT03372772

Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients

NCT03372772

RandomizedParallel-groupSingle-blindTreatment

Summary

It has been observed that despite administration of apparently adequate thyroid hormone replacement in hypothyroid patients, many of them experience persistent fatigue and fatigue-related symptoms. Carnitine transports long chain fatty acids into the mitochondria whereupon the high energy source (ATP) becomes synthesized. Levocarnitine administration reduced fatigue related symptoms in hypothyroid patients receiving thyroid hormone replacement. The present study deals with alleviation of fatigue in hypothyroid patients by carnitine supplementation.

Timeline

Start
2017-03-16
Primary completion
2017-12-30
Completion
2018-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 2000 mg Oral

Indications

No indication recorded.